P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808Jonathan E. Kolitz, Stephen L. George, Guido Marcucci et al.|Blood|2010Cited by 129